Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer

NCT04920656 is registered in ClinicalTrials.gov with King Hussein Cancer Center as lead sponsor.

NCT NCT04920656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
Lead sponsor
King Hussein Cancer Center
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
February 1, 2025
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer